Treatment of Equine Sarcoid with an unspecific immunostimulant- Remarks on the epidemiology and the spontaneous regression of sarcoids;Zur Therapie des Equinen Sarkoids mit einem unspezifischen Immunstimulator - Beitrag zur Epidemiologie und zur spontanen Regression des Sarkoids

Schweizer Archiv fur Tierheilkunde

Volumn 139, Issue 9, 1997, Pages 385-391

  Studer, U ^a   Marti, Eliane ^b   Stornetta, D ^a   Lazary, S ^b   Gerber, H ^b  

^a Clinique du Vieux Château   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Equine sarcoid; Experimental therapy; Immunostimulant; Spontaneous tumour regression

Indexed keywords

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

BAYPAMUN HK; IMMUNOLOGICAL ADJUVANT; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HAPLOTYPE; HORSE; HORSE DISEASE; INTRALESIONAL DRUG ADMINISTRATION; MALE; SKIN TUMOR; TUMOR REGRESSION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DOUBLE-BLIND METHOD; FEMALE; HAPLOTYPES; HORSE DISEASES; HORSES; INJECTIONS, INTRALESIONAL; MALE; NEOPLASM REGRESSION, SPONTANEOUS; SKIN NEOPLASMS; VIRAL VACCINES;

EID: 0030623764     PISSN: 00367281     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Amtmann E., Müller K., Knapp A., Sauer G. (1985) Reversion of bovine papillomavirus-induced transformation and immortalization by a xanthate compound. Exp. Cancer Res 161, 541-550
2. Bertone A.L., McClure J.J. (1990): Therapy for sarcoids Compend Cont. Educ. Pract. Vet. 12, 262-265.
3. Biedermann A. (1983): Versuche über intermediäre Wirkungen von unspezifisch wirkenden Reizkörpern und Paramunitatsinducern bei kleinen Versuchstieren. Diss. med. vet. Hannover.
4. Bütner M., Mayr A. (1986): Tests on protection against viral diseases. Comp. Immunol. Microbiol Inf Dis., 9, 205-213.
5. Büttner M., Strube W., Wolf G, Hoerstke M (1987): Parapoxvirus als Induktor unspezifischer Abwehrmechanismen. Tierärztl Umschau 42, 14-21.
6. Diebl M., Vingerhoets M., Stornetta D. (1987): Spezifische Methoden zur Entfernung des Equinen Sarkoides. Prakt. Tierarzt, Collegium veterinarium XVIII, 14-16
7. Dubath M.-L. (1986). Recherche d'association entre le système ELA et une prédisposition aux sarcoides équines Diss med. vet., Bern.
8. Gerber H., Dubath M.-L., Lazary S. (1988): Association between predisposition to equine sarcoid and MHC in multiple-case families. Equine Infectious Diseases V, Ed. D.G. Powell The University Press of Kentucky, pp. 272-277.
9. Houlton J.E.F (1983) Treatment of periocular equine sarcoids. Equine Vet.J Suppl. 2, 117-122.
10. Klein W.R. (1987): BCG-Immuntherapie für das Sarkoid beim Pferd. Prakt. Tierärzt, Collegium veterinarium XVIII, 17-18
11. Knottenbelt D.C., Walker J.A (1994). Topical treatment of the equine sarcoid. Equine vet Educ. 6, 72-75
12. Lane J G. (1977): The treatment of equine sarcoids by cryosurgery. Equine Vet.J. 9, 127-133.
13. Lavach J.D., Sullins K.E., Roberts S.M., Severin G.A., Wheeler C., Lueker D.C. (1985): BCG treatment of periocular sarcoid. Equine Vet.J. 17, 445-448
14. Lazary S., Gerber H., Glatt PA., Straub R. (1995): Equine leucocyte antigens (ELA) in sarcoid affected horses Equine vet J. 17, 283-286
15. Lazary S., Marti E., Szalat G., Gaillard C., Gerber H (1994): Studies on the frequency and associations of ELA antigens in sarcoid and summer dermatitis Animal Genetics 25, Suppl. 1, 75-80
16. Marti E., Lazary S., Antczak D.F., Gerber H. (1993) Report of the first international workshop on equine sarcoid Equine vet.J. 25, 397-407.
17. Mayr A., Büttner M., Pawlas S., Erfle V., Mayr B., Brunner R., Osterkorn K. (1986). Vergleichende Untersuchungen über die immunstimulierende (paramunisierende) Wirksamkeit von BCG, Levamisol, Corynebacterium parvum und Präparaten aus Pockenviren in verschiedenen «in vivo»- und «in vitro»-Testen.J Vet Med B 33, 321-339.
18. Mayr A., Büttner M., Wolf G., Meyer H., Czerny C. (1989): Experimenteller Nachweis paraspezifischer Wirkungen von gereinigten und inaktivierten Pockenviren J Vet. Med B 36, 81-99.
19. Metcalf J.W. (1971): Improved technique in sarcoid removal. Am. Ass. Equine Pract Proc. 17, 45-47
20. Mohammed H.O., Rebhun W.C., Antczak D.F. (1992): Factors associated with the risk of developing sarcoid tumors in horses Equine Vet.J 24, 165-168
21. Otten N (1992) DNA of bovine papillomavirus type 1 and 2 in equine sarcoids: PCR detection and direct sequencing. Diss. med. vet, Bern.
22. Otten N., von Tscharner C., Lazary S., Antczak D.F., Gerber H. (1993) DNA of bovine papillomavirus type 1 and 2 in equine sarcoids. PCR detection and direct sequencing. Arch Virol. 132, 121-131
23. Otten N., Marti E., Soderström C, Amtmann E., Burger D, Gerber H., Lazary S. (1994). A contribution to the therapy of equine sarcoids: Experimental treatment using a xanthate compound and recombinant human tumor necrosis factor J vet Med A41, 757-765.
24. Ragland W.L., Keown G.H., Spencer G.R (1970): Equine sarcoid. Equine Vet.J. 2, 2-11.
25. Reubel G., Büttner A (1986): Enhancement of nonspecific antiviral defense mechanisms in mice by poxvirus-derived biological modifiers. First International Vet. Congress 1986 Toronto, Canada.
26. Sauer G., Amtmann E., Melber K., Knapp A., Muller K., Hummel K., Seherin A. (1984): DNA and RNA virus species are inhibited by xanthates, a class of antiviral compounds with unique properties. Proc. Natl. Acad. Sci USA 81, 3263-3267
27. Steiner A. (1988): Prüfung des Immuntherapeutikums Nomagen zur Behandlung des equinen Sarcoids im Vergleich zur kryochirurgischen Therapie. Diss. med. vet, Zürich.
28. Strafuss A.C. Smith J E, Dennis S.M., Anthony H.D. (1973): Sarcoid in horses. Vet med./Small Anim. Clin. 68, 1246-1247.
29. Strube W., Thein P., Kretzdorn D., Grunmach J. (1989): Baypamun: Neue Möglichkeiten der Bekämpfung von Infektionskrankheiten bei Haustieren Vet. Med Nachr. 60, 3-15.
30. Tallberg Th., Kinnunen R E., Palkama A., Saarto E M.K , Borgström G. (1994): Equine sarcoid successfully treated by bio-immunotherapy. Dtsch.Zschr.Onkol. 26, 2, 34-40.
31. Teifke J.Pv., Weiss E. (1991): Nachweis boviner Papillomavirus-DNA in Sarkoiden des Pferdes mittels Polymerase-Kettenreaktion (PCR) Berl. Münch Tierarztl. Wschr. 104, 187-192
32. Thëon A.P., Pascoe J.R., Carlson G.P., Krag D.N. (1993): Intratumoral chemotherapy with cisplatin in oily emulsion in horses J. Am Vet. Med. Assoc 202, 261-267.
33. Torrontegui B.O., Reid S.W.J (1994): Clinical and pathological epidemiology of the equine sarcoid in a referral population. Equine vet. Educ. 6 (2), 85-88.
34. Vanselow B.A., Abetz I., Jackson A.R.B. (1988): BCG emulsion immunotherapy of equine sarcoid. Equine Vet.J. 20, 444-447
35. Vingerhoets M. (1987): Traitement des sarcoides équines au laser à gaz carbonique. Diss. med. vet , Bern
36. Vingerhoets M., Diehl M., Gerber H., Stornetta D., Rausis C. (1988): Traitement de la sarcoide équine au laser à gaz carbonique. Schweiz. Arch.Tierheilk. 130, 113-126
37. Wolf G. (1987). Kolonienstimulierende Aktivität in Mäuseseren nach Vorbehandlung mit Inducern aus Pockenviren und anderen Mikroorganismen. Diss. med. vet., Munchen.
38. Wyman M., Rings M.D., Tarr M.J., Alden C.L. (1977) Immunotherapy in equine sarcoid, A Report of two cases. J. Am Vet. Med.Assoc. 171, 449-451.